Casgevy

Casgevy (exagamglogene autotemcel) is a gene therapy designed to address genetic disorders. This intravenous treatment targets specific genetic mutations to potentially modify disease progression.

Casgevy is used to treat certain genetic conditions by modifying the patient's own cells. This therapy aims to address the root cause of the disorder, offering a potential long-term solution. Patients and healthcare providers should discuss whether Casgevy is suitable for their specific condition.

Casgevy may cause common side effects such as fatigue, fever, and injection site reactions. Some patients might experience more severe reactions, which should be discussed with a healthcare professional. The long-term effects of this therapy are still being studied.

Casgevy should be administered under strict medical supervision. Patients should inform their healthcare provider about any existing medical conditions or medications. Pregnant or breastfeeding women should consult their doctor before considering this treatment.

Casgevy may interact with other medications, particularly those that affect the immune system. Patients should avoid alcohol and certain supplements during treatment. Always consult a healthcare provider for personalized advice.